Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Efficacy of the ANAM General Neuropsychological Screening battery (ANAM GNS) for Detecting Neurocognitive Impairment in a Mixed Clinical Sample.
Neurogenic detrusor overactivity: an update on management options.
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Longitudinally Extensive Varicella-Zoster Virus Myelitis in a Multiple Sclerosis Patient.
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging.
Cognitive Processing Speed is Related to Fall Frequency in Older Adults with Multiple Sclerosis.
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.]
Cytomegalovirus ischemic colitis and transverse myelitis in a renal transplant recipient.
Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
How I treat POEMS syndrome.
Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of abcd1-deficient mice.
Multiple sclerosis guideline production takes off.
A modality-agnostic patch-based technique for lesion filling in multiple sclerosis.
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
Neurology issues in schizophrenia.
Varicella-zoster virus encephalomyelitis with a prominent demyelinating component.
Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis.
Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.
[Anaesthetic management of patient with neurological disease: Focus on regional anaesthesia.]
Vitamin D in allergic disorders.
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.
Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study.
Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis.
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review.
Novel therapeutics in multiple sclerosis management: clinical applications.

Pages